1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Abstract Text:

E B van Eden,H C Falkson,G Falkson,

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Publishing Authors By Initials

EB van Eden,HC Falkson,G Falkson,

For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

PUBMED ID PMID:

MEDLINE DATE:

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cancer chemotherapy reports. Part 1

VOLUME: 54

Page Numbers: 347-59

Journal Abbreviation:

ISSN: 0069-0112

DAY: 20

MONTH: Oct

YEAR: 1970

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7607105

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Keywords Mesh Terms:

KEYWORDS: Urea

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer. Information

Substance Name: Urea

Registry Number: 57-13-6

Grant and Affiliation Information for 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cancer Chemother Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

1,3-bis2-chloroethyl-1-nitrosourea BCNU; NSC-409962 given concomitantly with cytosine arabinoside NSC-63878 in the treatment of cancer Related Publications

• 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
• 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
• AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER.
• CLINICAL EVALUATION OF BIS(2-CHLOROPROPYL)CARBAMIC ACID, ETHYL ESTER (6W54, NSC-53105).
• Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
• Clinical experience with 1,4-dihydracryloylpiperazine, dimethanesulfonate (NSC-47774).
• Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
• DL-Serine bis(2-chloropropyl)carbamate ester (CB-3210; NSC-37023) for treatment of cancer patients. Preliminary results.
• Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
• Methyl-GAG (NSC-32946) in the treatment of esophagus cancer.